https://clarivate.com/life-sciences-healthcare/blog/life-sciences-licensing-deals-fourth-quarter-2017-updates-trends/ 2018-02-02T13:17:10+00:00 https://clarivate.com/wp-content/uploads/2018/02/mina.gif https://clarivate.com/wp-content/uploads/2018/02/table1.gif https://clarivate.com/life-sciences-healthcare/blog/ingredients-good-deal-biopharma-ambition-creativity-win-wins-cool-science-cross-border-intrigue/ 2018-01-30T09:29:27+00:00 https://clarivate.com/life-sciences-healthcare/blog/steps-taken-streamline-regulatory-processes-middle-east/ 2018-01-22T10:43:31+00:00 https://clarivate.com/life-sciences-healthcare/blog/sublocade-approval-likely-game-changer-u-s-fight-opioid-addiction/ 2018-01-17T14:23:12+00:00 https://clarivate.com/life-sciences-healthcare/blog/device-advice-value-use-of-patient-reported-outcome-measures-assessing-medical-devices/ 2018-01-12T09:45:10+00:00 https://clarivate.com/life-sciences-healthcare/blog/predictive-analytics-yield-better-disease-forecasting-example-ms/ 2018-01-09T10:36:29+00:00 https://clarivate.com/life-sciences-healthcare/zh/blog/generic-drug-globalization-how-to-collect-full-patent-portfolio/ 2018-01-08T06:17:04+00:00 https://clarivate.com/life-sciences-healthcare/blog/how-can-pharma-reps-respect-physicians-time-we-asked-20-doctors/ 2017-12-08T13:06:01+00:00 https://clarivate.com/life-sciences-healthcare/blog/green-light-market-hemlibra-hemophilia-inhibitors-us/ 2017-11-30T14:59:40+00:00 https://clarivate.com/wp-content/uploads/2017/11/LSfig1.jpg https://clarivate.com/life-sciences-healthcare/blog/notable-licensing-deals-biopharma-industry-q3-2017/ 2017-11-21T10:38:46+00:00 https://clarivate.com/life-sciences-healthcare/blog/tradition-bound-biopharma-industry-resisting-change-no-longer-option/ 2017-11-16T14:22:53+00:00 https://clarivate.com/life-sciences-healthcare/blog/car-t-cell-gene-therapies-enter-u-s-market/ 2017-10-10T10:53:08+00:00 https://clarivate.com/life-sciences-healthcare/blog/digitizing-pharmas-pivot-to-payer-marketing/ 2017-09-27T22:46:06+00:00 https://clarivate.com/life-sciences-healthcare/blog/biosimilars-opportunities-challenges-eu-u-s-russia/ 2017-09-14T12:36:59+00:00 https://clarivate.com/wp-content/uploads/2017/09/FDAbiosiliar.jpg https://clarivate.com/life-sciences-healthcare/blog/blockbuster-parp-inhibitor-fight-intensifies-focus-ovarian-cancer/ 2017-08-31T08:10:54+00:00 https://clarivate.com/life-sciences-healthcare/blog/fdas-carrot-stick-approach-pediatric-drugs-working/ 2017-08-23T07:34:53+00:00 https://clarivate.com/life-sciences-healthcare/blog/notable-licensing-deals-biopharma-industry-q2-2017/ 2017-08-10T09:03:10+00:00 https://clarivate.com/wp-content/uploads/2017/08/blog.jpg https://clarivate.com/life-sciences-healthcare/blog/second-remicade-biosimilar-offers-glimpse-competitive-u-s-market-future/ 2017-08-08T08:14:54+00:00 https://clarivate.com/life-sciences-healthcare/blog/rd-spend-capital-makes-shorter-runways-midmarket-biotech-companies/ 2017-08-03T07:57:03+00:00 https://clarivate.com/wp-content/uploads/2017/08/rd.jpg https://clarivate.com/life-sciences-healthcare/blog/lung-cancer-continued-progress-personalized-care/ 2017-07-19T14:22:52+00:00 https://clarivate.com/life-sciences-healthcare/blog/fda-approval-regulation-medical-devices-primer-2/ 2017-06-22T07:23:45+00:00 https://clarivate.com/life-sciences-healthcare/blog/positive-outlook-for-cdmos-at-cphi-north-america-but-companies-need-to-be-ready-for-challenges/ 2017-05-31T14:08:27+00:00 https://clarivate.com/life-sciences-healthcare/blog/dcat-week-17-session-looks-at-emerging-pharma-market-trends/ 2017-05-25T09:00:56+00:00 https://clarivate.com/life-sciences-healthcare/blog/victories-in-huntingtons-disease-few-and-far-between-but-resolve-remains-undimmed/ 2017-05-16T11:00:17+00:00 https://clarivate.com/life-sciences-healthcare/blog/roches-ocrevus-to-dominate-the-multiple-sclerosis-market/ 2017-04-26T09:48:35+00:00 https://clarivate.com/life-sciences-healthcare/ko/blog/pharma-product-launches-demand-real-world-marketing-data-inputs/ 2017-04-17T20:09:25+00:00 https://clarivate.com/life-sciences-healthcare/blog/preserving-boosting-innovation-crucial-in-age-of-brexit-trump/ 2017-03-21T07:59:48+00:00 https://clarivate.com/life-sciences-healthcare/blog/shifts-in-the-fdas-approach-to-off-label-promotion/ 2016-12-14T09:38:59+00:00 https://clarivate.com/life-sciences-healthcare/blog/advances-in-alzheimers-but-knowledge-gaps-remain/ 2016-12-14T09:38:36+00:00 https://clarivate.com/life-sciences-healthcare/blog/effective-product-selection-and-partner-identification-within-the-generics-and-active-ingredient-landscape/ 2016-11-30T14:59:14+00:00 https://clarivate.com/life-sciences-healthcare/blog/medical-devices-japan-regulatory-outlook-2017/ 2016-11-15T17:00:38+00:00